Tradestie Institutional Equity Comparison Engine

DMAC vs EDIT โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

DMAC Overall Edge

DMAC Captures Institutional Edge (3โ€“0 Pillars ยท 6โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to DiaMedica Therapeutics Inc. Common Stock (DMAC) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, DMAC trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus EDIT at N/M Forward P/E and -167.0% operating margin (+37.4% YoY). In options structure, DMAC sits in SURGE (14th %ile IV; Dealer Gamma Walls on Pro) against EDIT sits in BREAKDOWN (38th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
DMAC N/M vs EDIT N/M Fwd P/E
Growth & Margin Winner DMAC
Op Margin 0.0% vs -167.0% ยท YoY +0.0% vs +37.4%
Momentum & Technical Winner DMAC
1Y +55.3% vs -25.0% ยท 52W Pos 55% vs 11%
Options & Structure Winner DMAC
SURGE (14th %ile IV) vs BREAKDOWN (38th %ile IV)
DMAC NASDAQ
DiaMedica Therapeutics Inc. Common Stock
Pharmaceutical Preparations
$8.41
-4.27% 1D
Market Cap $503.1M
1M Return +11.16%
1Y Return +55.26%
Forward P/E N/M
Unified AI Score
46.3 / 100 HOLD
Tech 30.0 Fund 51.0 Flow 65.0 Mom 60.0
EDIT NASDAQ
Editas Medicine, Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$1.91
-12.21% 1D
Market Cap $336.5M
1M Return -18.94%
1Y Return -25.0%
Forward P/E N/M
Unified AI Score
48.4 / 100 HOLD
Tech 33.0 Fund 55.0 Flow 69.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: DMAC +55.26% EDIT -25.0% Spread: +80.26 pp (DMAC Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period DMAC Revenue EDIT Revenue DMAC Op. Margin EDIT Op. Margin Margin Edge
FY2018 $0M $30M -1352.2% -356.1% EDIT
FY2019 N/A $20M N/A -686.4% EDIT
FY2020 N/A $90M N/A -148.6% EDIT
FY2021 N/A $30M N/A -756.1% EDIT
FY2022 N/A $20M N/A -1146.3% EDIT
FY2023 N/A $80M N/A -216.6% EDIT
FY2024 N/A $30M N/A -777.2% EDIT
FY2025 N/A $40M N/A -394.9% EDIT

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: DMAC (6) vs EDIT (2)
Institutional Metric DMAC EDIT Criterion Row Winner
Market Capitalization Scale $503.1M $336.5M Larger Scale DMAC
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +0.0% +37.4% Higher Growth EDIT
Operating Margin (TTM) Profitability 0.0% -167.0% Higher Margin DMAC
Net Profit Margin Profitability 0.0% -144.9% Higher Margin DMAC
Return on Equity (ROE) Capital Efficiency -114.6% -147.4% Higher ROE DMAC
52-Week Range Position Momentum 55% ($5โ€“$11) 11% ($2โ€“$4) Stronger Trend DMAC
Beta / 30D Volatility Risk Regime 1.74ฮฒ ยท 98% Vol 2.32ฮฒ ยท 102% Vol Lower Realized Risk DMAC
Unified Institutional Score Composite Signal 46.3 / 100 (HOLD) 48.4 / 100 (HOLD) Higher Composite EDIT

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full DMAC vs EDIT Buy Guide
DMAC SURGE
8d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 14th %ile
IV Regime Compressed (<25th %ile)
Live DMAC Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
EDIT BREAKDOWN
146d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 38th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live EDIT Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither DMAC nor EDIT registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.